Adapsyn Bioscience: Adapsyn Bioscience receives funding to discover novel therapeutics for tuberculosis
Adapsyn Bioscience Inc. today announced that it has received funding from the Bill & Melinda Gates Foundation to find novel therapeutics that target tuberculosis (TB).
Read full article »
Adapsyn is a Canada-based chemical bioinformatics platform that develops novel small molecule therapies for the treatment of patients with tuberculosis.
Read more